A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo.
Mehrabi
Don
D
Pandya
Amit G
AG
D000279:Administration, Cutaneous; D004311:Double-Blind Method; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D011701:PUVA Therapy; D012720:Severity of Illness Index; D016559:Tacrolimus / Q000008:administration & dosage*; D016896:Treatment Outcome; D014466:Ultraviolet Rays; D014467:Ultraviolet Therapy; D014820:Vitiligo / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*
D007166:Immunosuppressive Agents; D016559:Tacrolimus